Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Beissert
Markus Beissert, Freiburg DE
| Patent application number | Description | Published |
|---|---|---|
| 20110317390 | Electronics housing for an electronic device, and a device formed therewith - An electronics housing comprises a housing basic body having a cavity, especially a single cavity. The housing basic body includes a side wall laterally bordering the cavity, an open end and a rear wall bounding the cavity on an end lying opposite the open end and remote therefrom. Also included is a housing lid releasably connected to the housing basic body on the open end and sealing the housing basic body; and an intermediate floor. The intermediate floor, in the case of the electronics housing of the invention, forms: a gap extending between an inner surface of the side wall of the housing basic body and a lateral surface of the intermediate floor facing the inner surface; and two housing chambers in the cavity of the housing basic body separated from one another by the intermediate floor. A first housing chamber is arranged on a first side of the intermediate floor facing the housing lid and a second housing chamber is arranged on a second side of the intermediate floor facing away from the housing lid. The intermediate floor is inserted into, and releasably affixed to, the housing basic body. | 12-29-2011 |
Stefan Beissert, Münster DE
| Patent application number | Description | Published |
|---|---|---|
| 20090162426 | Use of a Compound with RANKL Activity - The present invention relates to the use of a compound with receptor activator of nuclear factor-kB ligand (RANKL) activity for the manufacture of a topical pharmaceutical formulation for the modulation of local or systemic Treg numbers and the treatment or the prevention of skin-associated or systemic diseases. | 06-25-2009 |
Stefan Beissert, Münster DE
| Patent application number | Description | Published |
|---|---|---|
| 20090162426 | Use of a Compound with RANKL Activity - The present invention relates to the use of a compound with receptor activator of nuclear factor-kB ligand (RANKL) activity for the manufacture of a topical pharmaceutical formulation for the modulation of local or systemic Treg numbers and the treatment or the prevention of skin-associated or systemic diseases. | 06-25-2009 |
Tim Beissert, Griesheim DE
| Patent application number | Description | Published |
|---|---|---|
| 20110065103 | USE OF RNA FOR REPROGRAMMING SOMATIC CELLS - The present invention provides methods for de-differentiating somatic cells into stem-like cells without generating embryos or fetuses. More specifically, the present invention provides methods for effecting the de-differentiation of somatic cells to cells having stem cell characteristics, in particular pluripotency, by introducing RNA encoding factors inducing the de-differentiation of somatic cells into the somatic cells and culturing the somatic cells allowing the cells to de-differentiate. | 03-17-2011 |